Double labeling of cell surface antigens imaged with backscattered electrons

Acta Pathologica Microbiologica ScandinavicaVolume 64, Issue 4 p. 534-542 Article A URONIC AND SIALIC ACID FREE CHICK ALLANTOIC MUCOPOLYSACCHARIDE SULPHATE WHICH COMBINES WITH INFLUENZA VIRUS HI-ANTIBODY TO HOST MATERIAL 1. Purification of the Substance GUNNAR HAUKENES, GUNNAR HAUKENES The National Institute of Public Health, Virus Department B, Oslo, Norway. (Head: A. Harboe, M.D.)Search for more papers by this authorARILD HARBOE, ARILD HARBOE The National Institute of Public Health, Virus Department B, Oslo, Norway. (Head: A. Harboe, M.D.)Search for more papers by this authorKAREN MORTENSSON-EGNUND, KAREN MORTENSSON-EGNUND The National Institute of Public Health, Virus Department B, Oslo, Norway. (Head: A. Harboe, M.D.)Search for more papers by this author GUNNAR HAUKENES, GUNNAR HAUKENES The National Institute of Public Health, Virus Department B, Oslo, Norway. (Head: A. Harboe, M.D.)Search for more papers by this authorARILD HARBOE, ARILD HARBOE The National Institute of Public Health, Virus Department B, Oslo, Norway. (Head: A. Harboe, M.D.)Search for more papers by this authorKAREN MORTENSSON-EGNUND, KAREN MORTENSSON-EGNUND The National Institute of Public Health, Virus Department B, Oslo, Norway. (Head: A. Harboe, M.D.)Search for more papers by this author First published: September 1965 https://doi.org/10.1111/apm.1965.64.4.534Citations: 40AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume64, Issue4September 1965Pages 534-542 RelatedInformation

Acta Pharmacologica et ToxicologicaVolume 59, Issue s7 p. 486-488 EXCRETION OF LEAD IN RAT BILE - THE ROLE OF GLUTATHIONE J. Alexander, J. Alexander Department of Toxicology, National Institute of Public Health, Oslo, Norway.Search for more papers by this authorJ. Aaseth, J. Aaseth Medical Department B, Aker Hospital, Oslo, Norway. Department of Toxicology, National Institute of Public Health, Oslo, Norway.Search for more papers by this authorA. Mikalsen, A. Mikalsen Department of Toxicology, National Institute of Public Health, Oslo, Norway.Search for more papers by this author J. Alexander, J. Alexander Department of Toxicology, National Institute of Public Health, Oslo, Norway.Search for more papers by this authorJ. Aaseth, J. Aaseth Medical Department B, Aker Hospital, Oslo, Norway. Department of Toxicology, National Institute of Public Health, Oslo, Norway.Search for more papers by this authorA. Mikalsen, A. Mikalsen Department of Toxicology, National Institute of Public Health, Oslo, Norway.Search for more papers by this author First published: December 1986 https://doi.org/10.1111/j.1600-0773.1986.tb02809.xCitations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume59, Issues7December 1986Pages 486-488 RelatedInformation

Acta Pathologica Microbiologica ScandinavicaVolume 63, Issue 1 p. 79-90 Article POLYOMA VIRUS 2. Further Studies on the Interaction of Polyoma Virus with Mouse Embgo Cells at Low Temperature K. HELGELAND, K. HELGELAND The Virus Department A, National Institute of Public Health, Oslo Norway.Search for more papers by this authorJ. JONSEN, J. JONSEN The Virus Department A, National Institute of Public Health, Oslo Norway.Search for more papers by this authorO. LAHELLE, O. LAHELLE The Virus Department A, National Institute of Public Health, Oslo Norway.Search for more papers by this author K. HELGELAND, K. HELGELAND The Virus Department A, National Institute of Public Health, Oslo Norway.Search for more papers by this authorJ. JONSEN, J. JONSEN The Virus Department A, National Institute of Public Health, Oslo Norway.Search for more papers by this authorO. LAHELLE, O. LAHELLE The Virus Department A, National Institute of Public Health, Oslo Norway.Search for more papers by this author First published: July 1965 https://doi.org/10.1111/apm.1965.63.1.79Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume63, Issue1July 1965Pages 79-90 RelatedInformation

Acta Pathologica Microbiologica ScandinavicaVolume 68, Issue 3 p. 451-457 Article GLUCOSE-62,3,5-TRIPHENYLTETRAZOLIUM-CHLORIDE-REDUCTASE IN CELL CULTURE E. TJÖTTA, E. TJÖTTA Virus Department A, The National Institute of Public Health, Oslo, Norway. (Head: Professor O. Lahelle, M.D.)Search for more papers by this author E. TJÖTTA, E. TJÖTTA Virus Department A, The National Institute of Public Health, Oslo, Norway. (Head: Professor O. Lahelle, M.D.)Search for more papers by this author First published: November 1966 https://doi.org/10.1111/apm.1966.68.3.451AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume68, Issue3November 1966Pages 451-457 RelatedInformation

Climate change is arguably the greatest threat to population health worldwide. Urgent action is needed to mitigate and adapt to the impacts. National public health institutes (NPHIs) are key actors in preventing illness and improving the health and wellbeing of their populations. They therefore have a crucial role to play in addressing climate change and making it central to their agendas. They can contribute to a better understanding of how climate change affects health, translate this knowledge into policy advice, and identify health co-benefits and possible harms of mitigation and adaptation measures to support the implementation of healthy measures within and beyond the health sector. NPHIs are also responsible for reducing their own footprint through “greening” and can role model and support other organisations in this regard. The International Association of National Public Health Institutes (IANPHI) recognises the threat that climate change poses and, to this end, published the “IANPHI Roadmap for Action on Health and Climate Change” in November 2021. This roadmap highlights the essential role of NPHIs’ as “key climate actors”. NPHIs are at different stages of progress on climate change and health, and there is therefore need and opportunity to learn from best practices and to liaise and work together to address shared challenges. It is also essential that NPHIs have an ongoing collaboration with other actors, such as academics, civil society, NGOs and other non-state actors, within and beyond the health sector, in order to learn from other perspectives and sources of knowledge and to ensure coherence and joint action on climate change and health across the system. This workshop therefore aims to promote discussion and exchange and to raise the visibility of NPHIs as key climate actors in order to strengthen their individual and shared contribution. The workshop will also ensure that the IANPHI Roadmap remains front of mind a year after publication. It will also give the opportunity to NPHIs to share their progress since then, as well as promote coherence and exchange in their continued efforts. The workshop will start with a presentation of the IANPHI Roadmap, followed by three examples from NPHIs on their progress on climate change strategy development and implementation. It will then be followed by an interactive session and discussion on NPHIs’ priorities in this area, on how NPHIs and other actors can best exchange and work together, and on how IANPHI as a global network of NPHIs can promote and support NPHI and stakeholder cooperation. The presentations are coherent together in offering the Roadmap's vision as well as a set of diverse examples that illustrate the role of NPHIs on climate change and health in practice. Key messages • Emphasis of the important role that NPHIs have in addressing climate change and health, as well as the value of their partnerships and intersectoral working, which can be supported by IANPHI. • Promotion of discussion and new ideas between the presenters and the audience on how to ensure health is at the forefront when tackling climate change.

Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future

7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics

Pediatric Allergy and ImmunologyVolume 4, Issue S4 p. 13-18 Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro R. Sehmi, R. Sehmi Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorG. M. Walsh, G. M. Walsh Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorA. Hartnell, A. Hartnell Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorJ. Barkans, J. Barkans Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorJ. North, J. North Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorA. B. Kay, A. B. Kay Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorR. Moqbel, Corresponding Author R. Moqbel Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United Kingdom*Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Dovehouse St., London SW3 6LY, United KingdomSearch for more papers by this author R. Sehmi, R. Sehmi Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorG. M. Walsh, G. M. Walsh Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorA. Hartnell, A. Hartnell Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorJ. Barkans, J. Barkans Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorJ. North, J. North Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorA. B. Kay, A. B. Kay Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United KingdomSearch for more papers by this authorR. Moqbel, Corresponding Author R. Moqbel Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United Kingdom*Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Dovehouse St., London SW3 6LY, United KingdomSearch for more papers by this author First published: December 1993 https://doi.org/10.1111/j.1399-3038.1993.tb00333.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume4, IssueS4December 1993Pages 13-18 RelatedInformation

Journal of Cutaneous PathologyVolume 10, Issue 6 p. 550-558 AIDS: a medical conundrum R.E. Stahl, Corresponding Author R.E. Stahl Departments of Pathology, Immunology, and Dermatology, Manhattan VA Medical Center, and New York University Medical Center, U.S.A.Address: Dr. Rosalyn E. Stahl Department of Immunology, Room 16029 W, Manhattan VA Medical Center, 408 First Avenue, New York, New York 10010, U.S.A.Search for more papers by this authorA. Friedman-Kien, A. Friedman-Kien Departments of Pathology, Immunology, and Dermatology, Manhattan VA Medical Center, and New York University Medical Center, U.S.A.Search for more papers by this authorS. Zolla-Pazner, S. Zolla-Pazner Departments of Pathology, Immunology, and Dermatology, Manhattan VA Medical Center, and New York University Medical Center, U.S.A.Search for more papers by this author R.E. Stahl, Corresponding Author R.E. Stahl Departments of Pathology, Immunology, and Dermatology, Manhattan VA Medical Center, and New York University Medical Center, U.S.A.Address: Dr. Rosalyn E. Stahl Department of Immunology, Room 16029 W, Manhattan VA Medical Center, 408 First Avenue, New York, New York 10010, U.S.A.Search for more papers by this authorA. Friedman-Kien, A. Friedman-Kien Departments of Pathology, Immunology, and Dermatology, Manhattan VA Medical Center, and New York University Medical Center, U.S.A.Search for more papers by this authorS. Zolla-Pazner, S. Zolla-Pazner Departments of Pathology, Immunology, and Dermatology, Manhattan VA Medical Center, and New York University Medical Center, U.S.A.Search for more papers by this author First published: December 1983 https://doi.org/10.1111/j.1600-0560.1983.tb01506.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume10, Issue6December 1983Pages 550-558 RelatedInformation

AllergyVolume 55, Issue 3 p. 302-302 Effect of SIT on quality of life M. Yılmaz, M. Yılmaz Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this authorG. Bingöl, G. Bingöl Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this authorD. Altıntaş, D. Altıntaş Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this authorS. G. Kendirli, S. G. Kendirli Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this author M. Yılmaz, M. Yılmaz Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this authorG. Bingöl, G. Bingöl Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this authorD. Altıntaş, D. Altıntaş Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this authorS. G. Kendirli, S. G. Kendirli Department of Pediatric Allergy and Immunology, Cukurova University, Faculty of Medicine, TR-01330, Adana, TurkeySearch for more papers by this author First published: 09 October 2008 https://doi.org/10.1034/j.1398-9995.2000.00448.xCitations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume55, Issue3March 2000Pages 302-302 RelatedInformation

Australian and New Zealand Journal of MedicineVolume 8, Issue s1 p. 177-178 IS MIXED CONNECTIVE TISSUE DISEASE A REAL ENTITY IDENTIFIABLE BY ANTIBODIES TO RIBONUCLEOPROTEIN? M. L. Cohen, M. L. Cohen Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this authorB. Dawkins, B. Dawkins Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this authorR. L. Dawkins, R. L. Dawkins Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this authorE. T. Owen, E. T. Owen Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this author M. L. Cohen, M. L. Cohen Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this authorB. Dawkins, B. Dawkins Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this authorR. L. Dawkins, R. L. Dawkins Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this authorE. T. Owen, E. T. Owen Departments of Rheumatology and Clinical Immunology, Queen Elizabeth II Medical Centre and Royal Perth Hospital, Perth, WASearch for more papers by this author First published: June 1978 https://doi.org/10.1111/j.1445-5994.1978.tb04831.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume8, Issues1June 1978Pages 177-178 RelatedInformation

British Journal of DermatologyVolume 151, Issue 3 p. 707-708 Anaphylaxis to hydrocortisone hemisuccinate with cross-sensitivity to related compounds in a paediatric patient G.F. Calogiuri, G.F. Calogiuri Allergist-Medical Consultant for Allergy and Clinical Immunology Specialty at Civil Law Court, Lecce, Allergy and Clinical Immunology Service, Vito Fazzi Hospital, Lecce, ItalySearch for more papers by this authorL. Muratore, L. Muratore Allergist-Medical Consultant for Allergy and Clinical Immunology Specialty at Civil Law Court, Lecce, Allergy and Clinical Immunology Service, Vito Fazzi Hospital, Lecce, ItalySearch for more papers by this authorE. Nettis, E. Nettis Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this authorM.T. Ventura, M.T. Ventura Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this authorA. Ferrannini, A. Ferrannini Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this authorA. Tursi, A. Tursi Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this author G.F. Calogiuri, G.F. Calogiuri Allergist-Medical Consultant for Allergy and Clinical Immunology Specialty at Civil Law Court, Lecce, Allergy and Clinical Immunology Service, Vito Fazzi Hospital, Lecce, ItalySearch for more papers by this authorL. Muratore, L. Muratore Allergist-Medical Consultant for Allergy and Clinical Immunology Specialty at Civil Law Court, Lecce, Allergy and Clinical Immunology Service, Vito Fazzi Hospital, Lecce, ItalySearch for more papers by this authorE. Nettis, E. Nettis Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this authorM.T. Ventura, M.T. Ventura Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this authorA. Ferrannini, A. Ferrannini Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this authorA. Tursi, A. Tursi Allergy and Clinical Immunology Department, Department of Internal Medicine Immunology and Infectious Diseases, Bari University, Policlinico, Piazza G. Cesare, 11-70124 Bari, ItalySearch for more papers by this author First published: 16 September 2004 https://doi.org/10.1111/j.1365-2133.2004.06102.xCitations: 14 Dr Mariateresa Ventura. E-mail: mt.ventura@allergy.uniba.it Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume151, Issue3September 2004Pages 707-708 RelatedInformation

AllergyVolume 53, Issue s46 p. 139-142 Importance of food allergy in atopic dermatitis A. Oehling, Corresponding Author A. Oehling Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainDepartment of Allergology and Clinical Immunology University Clinic Faculty of Medicine Universih of Navarre SpainSearch for more papers by this authorA. Resano, A. Resano Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainSearch for more papers by this authorM. L. Sanz, M. L. Sanz Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainSearch for more papers by this authorM. Fernandez Benitez, M. Fernandez Benitez Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainSearch for more papers by this author A. Oehling, Corresponding Author A. Oehling Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainDepartment of Allergology and Clinical Immunology University Clinic Faculty of Medicine Universih of Navarre SpainSearch for more papers by this authorA. Resano, A. Resano Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainSearch for more papers by this authorM. L. Sanz, M. L. Sanz Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainSearch for more papers by this authorM. Fernandez Benitez, M. Fernandez Benitez Department of Allergology and Cllnical Immunology. University Clinic, Faculty of Medicine, University of Navarre. SpainSearch for more papers by this author First published: 30 December 2008 https://doi.org/10.1111/j.1398-9995.1998.tb04985.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume53, Issues46October 1998Pages 139-142 RelatedInformation

Acta Pathologica Microbiologica Scandinavica Section B Microbiology and ImmunologyVolume 79B, Issue 5 p. 719-720 IMMUNOLOGICAL STUDIES ON THE L FORM OF AN E. COLI STRAIN Preliminary Report B. Kaijser, B. Kaijser Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this authorJ.-E. Brorson, J.-E. Brorson Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this authorL. A. Hanson, L. A. Hanson Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this authorS. Seeberg, S. Seeberg Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this author B. Kaijser, B. Kaijser Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this authorJ.-E. Brorson, J.-E. Brorson Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this authorL. A. Hanson, L. A. Hanson Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this authorS. Seeberg, S. Seeberg Departments of Clinical Bacteriology and Immunology, Institute of Medical Microbiology, University of Gö‘teborg, Gö’teborg, SwedenSearch for more papers by this author First published: September 1971 https://doi.org/10.1111/j.1699-0463.1971.tb00102.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume79B, Issue5September 1971Pages 719-720 RelatedInformation

Background: In the context of the fight against HIV, a lack of skills in monitoring and evaluating the personnel in charge of activities has been identified at the national level. It was the subject of a priority axis of the national plan for monitoring and evaluating the fight against HIV (2006-2010) that was aimed at strengthening the capacities of actors in this area. To increase the critical mass of competent human resources in the short term, the National Institute of Public Health (NIPH) of Côte d’Ivoire organized monitoring and evaluation training sessions for healthcare professionals from 2011 to 2016. Methods: A single case study with multiple levels of analysis was carried out, combining a qualitative survey and a literature review. An evaluation was carried out six months after each training session. In addition, the results of the pre- and post-tests and of the daily and final evaluations that accompanied the various training sessions were used to provide further information. The qualitative data collected were analyzed using INVIVO 15 software. Results: Some 89 health professionals (69% men and 31% women) working at the national level (51% at the central level, including 58% in health programs) and in development partner agencies (37%) participated in this capacity building program. Most participants were senior health managers (56%), data managers (23%), and statisticians and computer scientists (10%). Almost all the trainings were financed by 16 technical and financial partners (85%), mainly the MEASURE Evaluation project (27%). Conclusion: M&E training, despite all its imperfections, has made it possible to identify M&E training needs at the national level and to increase the critical mass of national skills and to have some culture in M&E.